Zosano Pharma Corp (ZSAN.OQ)
ZSAN.OQ on NASDAQ Stock Exchange Capital Market
4.03USD
4:00pm EDT
4.03USD
4:00pm EDT
Change (% chg)
$0.03 (+0.75%)
$0.03 (+0.75%)
Prev Close
$4.00
$4.00
Open
$3.99
$3.99
Day's High
$4.03
$4.03
Day's Low
$3.93
$3.93
Volume
43,624
43,624
Avg. Vol
48,044
48,044
52-wk High
$25.80
$25.80
52-wk Low
$3.63
$3.63
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.00 | -0.752 |
| Mar '18 | 0.00 | -4.159 | |
| FY 2017 | Dec '17 | 0.00 | -3.799 |
| Sep '17 | 0.00 | -4.014 | |
| Jun '17 | 0.00 | -3.442 | |
| Mar '17 | 0.00 | -6.882 | |
| FY 2016 | Dec '16 | 0.00 | -9.205 |
| Sep '16 | 0.00 | -10.447 | |
| Jun '16 | 0.00 | -10.856 | |
| Mar '16 | 0.00 | -13.562 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-18 | 1 | 0.20 | 0.20 | 0.20 | 0.00 |
| Year Ending Dec-18 | 1 | 0.20 | 0.20 | 0.20 | 0.00 |
| Year Ending Dec-19 | 1 | 1.70 | 1.70 | 1.70 | 3.25 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 1 | -0.70 | -0.70 | -0.70 | -4.00 |
| Quarter Ending Dec-18 | 1 | -0.71 | -0.71 | -0.71 | -4.00 |
| Year Ending Dec-18 | 1 | -3.60 | -3.60 | -3.60 | -17.00 |
| Year Ending Dec-19 | 1 | -2.12 | -2.12 | -2.12 | -14.00 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 108.45 | 32.71 | |
| P/E High - Last 5 Yrs. | -- | 279.26 | 47.27 | |
| P/E Low - Last 5 Yrs. | -- | 98.01 | 24.80 | |
| Beta | 1.93 | 0.61 | 0.87 | |
| Price to Sales (TTM) | -- | 110.80 | 6.42 | |
| Price to Book (MRQ) | 1.33 | 12.48 | 3.91 | |
| Price to Tangible Book (MRQ) | 1.33 | 18.85 | 5.97 | |
| Price to Cash Flow (TTM) | -- | 62.31 | 23.27 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.35 | 1.69 | |
| Dividend Yield - 5 Year Avg | -- | 0.21 | 1.45 | |
| Dividend 5 Year Growth Rate | -- | 2.62 | -5.70 | |
| Payout Ratio(TTM) | -- | 5.94 | 46.55 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 179.03 | 8.45 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 93.99 | 6.71 | |
| Sales - 5 Yr. Growth Rate | -- | 24.50 | 7.56 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 78.16 | 283.55 | 25.51 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 57.55 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 23.64 | 7.60 | |
| Capital Spending - 5 Yr. Growth Rate | 126.21 | 38.63 | 8.37 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.64 | 2.20 |
| Current Ratio (MRQ) | 4.68 | 5.47 | 2.97 |
| LT Debt to Equity (MRQ) | 0.00 | 15.10 | 11.21 |
| Total Debt to Equity (MRQ) | 9.98 | 18.60 | 14.02 |
| Interest Coverage (TTM) | -27.64 | -198.17 | 35.35 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.03 | 54.73 | |
| Gross Margin - 5 Yr. Avg. | -- | 52.71 | 53.30 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -1,250.53 | -176.77 | 15.89 | |
| Operating Margin (TTM) | -- | -608.74 | 3.72 | |
| Operating Margin - 5 Yr. Avg. | -1,352.56 | -190.37 | 11.01 | |
| Pre-Tax Margin (TTM) | -- | -605.96 | 4.04 | |
| Pre-Tax Margin - 5 Yr. Avg. | -1,444.14 | -192.95 | 11.19 | |
| Net Profit Margin (TTM) | -- | -600.63 | 0.77 | |
| Net Profit Margin - 5 Yr. Avg. | -1,444.14 | -190.59 | 7.53 | |
| Effective Tax Rate (TTM) | -- | 11.58 | 20.44 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.15 | 24.27 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 5,333,198 | 715,149,750 | |
| Net Income/Employee (TTM) | -- | -5,689,194 | 82,590,366 | |
| Receivable Turnover (TTM) | -- | 4.22 | 5.01 | |
| Inventory Turnover (TTM) | -- | 2.06 | 3.61 | |
| Asset Turnover (TTM) | 0.00 | 0.38 | 0.82 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -81.14 | 0.77 | 9.73 | |
| Return on Assets - 5 Yr. Avg. | -88.99 | 2.50 | 10.90 | |
| Return on Investment (TTM) | -103.53 | 1.54 | 12.72 | |
| Return on Investment - 5 Yr. Avg. | -149.58 | 1.99 | 14.02 | |
| Return on Equity (TTM) | -111.67 | 0.30 | 14.84 | |
| Return on Equity - 5 Yr. Avg. | -435.88 | -2.37 | 15.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | 61.16 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Zosano Pharma Corp
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Zosano Appoints Steven Elms To Board Of Directors
- BRIEF-Zosano Pharma Q1 Loss Per Share $4.16
- BRIEF-Zosano Reaches Enrollment Milestone In M207-Adam Long-Term Safety Study
- BRIEF-Zosano Announces Pricing Of 10 Mln Common Shares At $5 per Share
- BRIEF-Zosano Pharma Corp Files For Offering 10 Mln Shares Of Co's Common Stock
Institutional Holders
| % Shares Owned: | 61.19% |
| # of Holders: | 35 |
| Total Shares Held: | 7,326,717 |
| 3 Mo. Net Change: | -259,630 |
| # New Positions: | 10 |
| # Closed Positions: | 16 |
| # Increased Positions: | 21 |
| # Reduced Positions: | 19 |
| # Net Buyers: | 2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.